NOMAD POWER SOLUTIONS, INC. Deferred Costs, Noncurrent
NOMAD POWER SOLUTIONS, INC. (NMAD) had Deferred Costs, Noncurrent of $198.83 thousand as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2025-08-07
- 2025-06-30: Deferred Costs, Noncurrent $198.83K.
- 2024-09-30: Deferred Costs, Noncurrent $6.93K.
- 2022-03-31: Deferred Costs, Noncurrent $10.91K.
- 2021-09-30: Deferred Costs, Noncurrent $26.38K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2025-06-30 | $198.83K 10-Q · filed 2025-08-07 |
| 2024-09-30 | $6.93K 10-Q · filed 2024-11-12 |
| 2022-03-31 | $10.91K 10-Q · filed 2022-05-11 |
| 2021-09-30 | $26.38K 10-Q · filed 2021-11-10 |
| 2020-09-30 | $174.25K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $86.85K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |